Improved Risk-Adjusted Survival for Melanoma Brain Metastases in the Era of Checkpoint Blockade Immunotherapies: Results from a National Cohort. uri icon

authors

  • Iorgulescu, J Bryan
  • Harary, Maya
  • Cheryl K. Zogg, PhD, MSPH, MHS
  • Ligon, Keith L
  • Reardon, David A
  • Hodi, F Stephen
  • Aizer, Ayal A
  • Smith, Timothy R

publication date

  • January 1, 2018